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ABSTRACT
Mutations involving cardiac ion channels result in
abnormal action potential formation or propagation,
leading to cardiac arrhythmias. Despite the large impact
on society of sudden cardiac death resulting from such
arrhythmias, understanding of the underlying cellular
mechanism is poor and clinical risk stratiﬁcation and
treatment consequently limited. Basic research using
molecular techniques, as well as animal models, has
proved extremely useful in improving our knowledge of
inherited arrhythmogenic syndromes. This offers the
practitioner tools to accurately diagnose rare disorders
and provides novel markers for risk assessment and
a basis for new strategies of treatment.
INTRODUCTION
Ion channels are pore-forming proteins that provide
pathways for the controlled trans-membrane
movement of ions. This is critical for a range of
physiological processes including action potential
(AP) generation and propagation, resulting in the
release of intracellular Ca
2+ stores triggering
mechanical activity. Abnormalities in cardiac ion
channel function or in their associated regulatory
proteins may lead to arrhythmias and sudden
cardiac death (SCD). SCD poses a major medical
challenge and signiﬁcant public health burden,
accounting for over 300000 deaths per year in the
USA,
1 and up to 70000 deaths per year in the UK,
2
with survival rates of only 2%. In the majority of
cases, the arrhythmias are a manifestation of
underlying ischaemic heart disease; however,
autopsy fails to reveal a cause in up to 40% of SCD
patients.
3
Despite the high prevalence and large impact on
society of cardiac arrhythmias, our understanding
of the cellular and molecular mechanisms
governing the initiation, maintenance and propa-
gation of arrhythmias remains limited. Conse-
quently, current risk stratiﬁcation of patients and
families with these conditions is inadequate and
the mainstay of treatment is often restricted to
implantable cardioverter deﬁbrillator implantation.
Although new techniques are being developed to
investigate the mechanisms that predispose to
SCD, invasive studies in humans are limited.
Therefore, basic research using molecular tech-
niques as well as animal models is essential in
improving our understanding of the mechanisms of
arrhythmogenesis at the cellular level. This review
forms the third paper in a series of inherited
channelopathy reviews published in this journal,
with the earlier papers discussing the impact of
pathophysiology
4 and the role of the Sudden Adult
Death Syndrome clinic
5a in the management of ion
channel disease. The current review will focus on
the role of basic science in investigating primary
electrical diseases of the heart as a paradigm for
cardiac arrhythmias, concentrating on Brugada
syndrome (BrS), long QT syndrome (LQTS) and
catecholaminergic polymorphic ventricular tachy-
cardia (CPVT).
MECHANISMS OF VENTRICULAR
ARRHYTHMOGENESIS
Normal cardiac excitability results from a balance
of depolarising and repolarising ionic currents. Each
ionic current can be distinguished by its ionic
selectivity and time course, which are properties
that are conferred by speciﬁc ion channels (for
more details see review by Behr et al
5b). Mutations
in any of the genes involved in regulation of
cardiac ion channels may potentially result in
arrhythmias and may be classiﬁed as arising from
either abnormal AP formation or abnormal AP
propagation (ﬁgure 1).
Abnormal AP formation
Abnormal AP formation may occur as a result of
enhanced automaticity, parasystole or triggered
activity. Enhanced automaticity describes the
accelerated depolarisation of pacemaker tissue that
might occur as a result of increased sympathetic
activity, hypokalaemia or drugs such as digitalis.
Parasystole refers to the parallel activation of two
of more pacemaker regions, which may override
their usual suppression through protection by
a region of conduction block. Both are rare causes of
arrhythmias.
6
Triggered activity describes the generation of
extra systoles produced in regions other than the
primary cardiac pacemaker (ﬁgure 1A). These are
usually produced by after-depolarisations. These are
oscillations of membrane potential that are a func-
tion of the preceding AP and which may generate
a premature AP, and if of sufﬁcient magnitude
locally to cause a propagated wave of depolarisation
can produce a triggered beat. Early after-depolar-
isations (EADs) occur during repolarisation of
the AP while delayed after-depolarisations (DADs)
do not occur until repolarisation is complete or
nearly complete. EADs occur when a prolonged
AP duration (APD) allows time for L-type Ca
2+
channels to recover from inactivation while the
membrane is still depolarised. When sufﬁcient
recovery has occurred, inward ICa-L further
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Reviewdepolarises the membrane and initiates the after-depolarisation,
thereby exerting a positive feedback effect.
7 DADs are caused by
enhanced Ca
2+ release from the sarcoplasmic reticulum (SR) due
to either to activation of the Na
+/Ca
2+ exchanger or Ca
2+
activated Cl
  current. Thus, DADs tend to occur under condi-
tions of Ca
2+ overload such as during digitalis toxicity and
CPVT.
8
Abnormal AP propagation: mechanisms of re-entry
The mammalian ventricular myocardium normally has a highly
regulated sequence of AP activation. Abnormal AP propagation
can occur when the depolarisation wavefront fails to completely
extinguish after normal activation, and can therefore lead to the
re-excitation of regions that have recovered excitability. This
circulating wave results in the spread of depolarisation, termed
re-entry (ﬁgure 1B).
There are three principal requirements for the initiation of
re-entrant arrhythmias:
< an obstacle around which the AP is able to circulate
< a conduction velocity sufﬁciently slow such that each region
recovers excitability before the wave returns
< an existence of unidirectional conduction block, preventing
the wave from self-extinguishing.
Such criteria have been demonstrated in numerous previous
experiments, the earliest of which used an anatomical block,
9 as
may be seen in patients with ventricular scarring, usually from
old myocardial infarction, but potentially also from cardiomy-
opathy and inﬁltrative disease. Mapping studies have shown the
development of a line of functional unilateral block, which
prevents the wave from self-extinguishing. The conduction
velocity is slowed so that each region recovers excitability before
the wave returns.
10 Re-entry can also occur in the absence of
scar, if there are regional heterogeneities in membrane excit-
ability. Unilateral block can result if there are spatial gradients in
the time taken between stimulation and depolarisation (latency)
or in the time taken between depolarisation and recovery from
the ventricular effective refractory period (VERP).
Spatial electrophysiological heterogeneity
The normal mammalian ventricular myocardium similarly has
a highly regulated sequence of repolarisation, proceeding from
epicardium to endocardium and from base to apex. The gradients
that are observed in the normal heart may serve to protect the
normal sequence of electro-mechanical activation and enable the
correctly timed mechanical contractile activity that enables
coordinated mechanical activation and relaxation of the heart.
These spatial differences are determined predominantly by
regional differences in repolarising K
+ channels, including varia-
tions in channel density, kinetics and cycling between membrane
and cytoplasm. Disturbances in these gradients may allow
depolarised regions to re-excite already repolarised areas and serve
as substrates for re-entry. Transmural gradients have been
Figure 1 Mechanisms contributing to
arrhythmogenesis. (A) Triggered
activity, the upper trace shows an early
after-depolarisation (EAD) occurring
during repolarisation. The lower trace
shows a delayed after-depolarisation
(DAD) occurring following
repolarisation. Dotted lines indicate the
generation of an extra action potential
with a sufﬁciently sized after-
depolarisation. (B) Re-entrant circuit,
the upper diagram shows a normal
pattern of excitation with impulse
propagating equally at each bifurcation
and extinguishing in the middle. The
lower diagram shows an area of
slowed conduction velocity in one of
the branches. The normal impulse
shown by the solid arrow does not get
extinguished as indicated by the
delayed dotted arrow, allowing it to
excite the myocardium. The delayed
impulse is then able to circulate around
the junctions resulting in inappropriate
excitation of the rest of the
myocardium. (C) Spatial
heterogeneities in the form of
transmural gradients. The epicardial
action potential duration is much
shorter than the endocardial potentially
leading to re-excitation. (D) Temporal
heterogeneities in the form of
discordant action potential duration
alternans. Regions which alternate out
of phase generate a line of block called
the nodal line between them. This has
the potential to act as a focus for re-
entrant circuits following the addition of
a triggered beat.
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Reviewsuggested to be particularly important as differences in repolar-
isation are exerted across a relatively short distance, with alter-
ations in transmural gradients correlated with arrhythmogenic
tendencies in a number of both pharmacological canine and
genetic murine models for LQTS and BrS (ﬁgure 1C). As well as
transmural gradients, heterogeneities within the ventricle from
base to apex have been demonstrated in a number of animal
models. Clinical increases in this dispersion have been associated
witharrhythmogenesisincardiomyopathiesandhavebeenlinked
with an increased incidence of Twave alternans and ventricular
tachycardia (VT).
11 Data from the canine right ventricular (RV)
wedge preparation
12 and the Scn5a
+/  mouse model
13 implicate
re-entry as a result of epicardial dispersion of repolarisation as the
trigger for ventricular arrhythmia. Last, differences in APDs
between the left ventricle and RV may play a role in arrhyth-
mogenesis in BrS, as demonstrated by electrocardiographic ST
elevation in the right precordial leads, RV delay and changes
speciﬁc to RVepicardial AP waveforms in BrS patients.
14
Temporal electrophysiological heterogeneity
As well as spatial heterogeneities, there may also be temporal
beat-to-beat variations in the AP amplitude or duration,
a phenomenon known as alternans (ﬁgure 1D). This has been
associated with arrhythmogenesis in both clinical
15 and experi-
mental
16 studies. Several hypotheses exist for the cellular
mechanism for the AP alternans itself; although there is a likely
role for SR Ca
2+ cycling, APD restitution is also a key. The latter
speciﬁcally concerns the attenuation of APD that occurs in
response to faster heart rates and is thought to be an adaptive
mechanism for preserving diastolic interval. At a given cycle
length, APD prolongation during one beat is necessarily followed
by a short diastolic interval, which will shorten APD in the
following beat, causing repeated shortelong cycles related to the
availability of depolarising channels.
Alternans phenomena have classically been analysed by the
construction of restitution curves relating APD to the preceding
diastolic interval as heart rate is varied.
17 The ‘restitution
hypothesis’ states that transient APD alternans will occur when
the slope of the restitution curve does not equal zero, becomes
sustained when it is at unity and becomes unstable when the
gradient exceeds one (ﬁgure 2). Relationships among restitution
curve slopes, alternans and arrhythmogencity have been estab-
lished in canine preparations made to model congenital LQTS
type 2
18 and of genetic mouse models of LQTS type 3 and BrS.
19
More recently, a predisposition of the RV for alternans has
been found in the Scn5a
+/  mouse model for BrS.
20 Although
concordant alternans itself may not be necessarily arrhythmo-
genic, it is a prerequisite for subsequent development of discor-
dant alternans. This can have signiﬁcant consequences on the
spatial organisation of repolarisation across the ventricle,
amplifying the heterogeneities of repolarisation present at
baseline into pathophysiological heterogeneities of sufﬁcient
magnitude to produce conduction block and re-entrant
excitation.
Figure 2 Restitution curve with action
potential duration (APDn) plotted
against the previous diastolic interval
(DIn 1). Both would be in the order of
milliseconds. The thick curve shows the
typical monoexponential relationship
this provides. Corresponding action
potentials (APs) are shown for each
numbered point. As the sum of the APD
and DI gives the Basic Cycle Length,
BCL, this gives the equation APD¼ DI
+BCL which is in the form of the linear
relationship y¼mx+c, with m the slope
and c the vertical intercept of the
function. Hence BCL represents the
y-axis and x-axis intercept connected
by a line with gradient of  1 (grey
lines). Moving from a given BCL to
another results in an iterative process
which takes the APD to a new steady-
state value. This is represented by the
dashed lines. Each time a dashed line
crosses the restitution function an AP is
ﬁred. At (1) the change in BCL results in
a rapid iteration to a new steady-state
value. As the gradient becomes
steeper, the system takes longer to
reach the steady-state value, with (2)
showing a transient set of alternans.
When the gradient of the restitution
function reaches unity (3), the system
enters a stable positive feedback, never
reaching a steady-state value and
producing sustained alternans. The DI
at this point is known as the critical
diastolic interval, DIcrit, and represents
the break-point between stability and
instability. Finally, surpassing the DIcrit (4) results in an unstable positive feedback, with AP durations spiralling away from each other. This is likely to
result in the occurrence of discordant alternans and wavebreak, leading to arrhythmia.
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ReviewMETHODS EMPLOYED IN BASIC ELECTROPHYSIOLOGICAL
STUDIES OF INHERITED CARDIAC ARRHYTHMIAS
In common with many ﬁelds of medicine, investigation of
inherited cardiac arrhythmias has relied on the translational
cycle of identifying clinical problems via a genetic approach
using familial studies, studying this genotype at the bench level
in order to reﬁne analysis techniques and to characterise the
underlying mechanism, followed by a move back into the clinic
in the form of risk stratiﬁcation and drug trials. A signiﬁcant
contribution has been made from the utilisation of animal
models including ferrets, rabbits, dogs, guinea pigs and rats,
although they are all limited by the use of non-speciﬁc phar-
macological agents to mimic the effects of genetic mutations.
The introduction of genetically engineered mice has provided
potentially more speciﬁc modelling opportunities. Despite
differences in size, basal rate and relative contribution of repo-
larising K
+ currents,
21 they reliably replicate many of the human
phenotypes. Structurally the sinoatrial node, atrioventricular
node and atrioventricular bundles are similar in murine and
human hearts and, importantly, the mouse shares similar
depolarising Na
+ currents to that of larger mammals including
humans.
22 Furthermore, both species have similar transmural
differences in APD,
23 share similar relationships between APD
and refractory period
24 and have near identical transmural
conduction velocities.
25 Genetic mouse models have yielded
important ﬁndings concerning mechanisms underlying
arrhythmogenicity in conditions including congenital LQT,
26e28
BrS
29 and CPVT.
30
CHANNELOPATHIES
Brugada syndrome
BrS is characterised electrocardiographically by right precordial
ST elevation, negative T-waves and RV delay, and clinically by
episodes of polymorphic VT and ventricular ﬁbrillation (VF).
While many genetic mutations have been associated with BrS,
all result in a general imbalance of currents in favour of
Figure 3 Mechanisms of
arrhythmogenesis in Brugada syndrome
from animal models. The scales
demonstrate that its associated genetic
mutations result in a loss of
depolarising currents or a gain of
repolarising currents. This in turn
results in delayed conduction velocity,
transmural action potential gradients,
a greater propensity to alternans and
potentially to phase 2 re-entry. The
lowest trace shows an ECG with the
initiation of a polymorphic ventricular
tachycardia recapitulating the clinical
phenotype. All traces shown are from
mice except phase 2 re-entry which is
from the canine wedge preparation.
Adapted in part from Martin et al,
29
Morita et al,
40 Matthews et al
20 and
Martin et al,
39 with permission. Decreased
depolarisation
currents
Depolarisation
Repolarisation
Brugada syndrome
Increased repolarisation currents
Transmural gradients
Slowed conduction
velocity
Polymorphic ventricular tachycardia
Phase 2 re-entry
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studied of these is the loss-of-function mutation of the SCN5A
gene, encoding the a-subunit of the voltage gated Na
+ channel.
The cause of ST elevation in BrS and its strong linkage to
VT/VF remains unresolved. Pathophysiological mechanisms
responsible for ST segment changes must operate during the
cardiac repolarisation phase, and these mechanisms must be
based on INa reduction. The proposed mechanism which origi-
nally appeared to receive the widest support, both from exper-
imental studies using a canine pharmacological ventricular
preparation
31 and some small clinical studies,
32 ascribes BrS to
a primary repolarisation disorder. The deep phase 1 notch in the
epicardial AP, particularly prominent in the RV, renders it
susceptible to the effects of a reduction in the Na
+ current. The
reduction in Na
+ current establishes a steep voltage gradient
across the RV wall due to short-circuiting of the epicardial AP
resulting in extreme shortening. The imbalance of currents
allows for reactivation of the RV epicardium by neighbouring
regions of myocardium, with longer APs producing functional
re-entry, referred to as phase 2 re-entry.
An alternative explanation for the ECG signature in BrS is
based on conduction delay in the right ventricular outﬂow tract
(RVOT).
33 There is clinical evidence implicating conduction
alterations, although this mainly employs non-invasive tech-
niques such as echocardiography, signal-averaged ECG and body
surface mapping.
34 35 A single ex vivo study of the heart from
a BrS patient has demonstrated local conduction delays in the
RVOT, but in an absence of transmural differences in repolar-
isation.
36 More recently, fractionated late potentials were found
exclusively in the anterior aspect of the RVOTepicardium in BrS
patients, and catheter ablation over this abnormal area resulted
in normalisation of the ECG pattern and prevented VT/VF.
37 So
far, there is only one available clinical study that has showed
both conduction and repolarisation disturbances.
38
Recent studies using a heterozygotic Scn5a
+/  mouse model
have shed further light on possible pathological mechanisms of
arrhythmogenesis. Affected mice demonstrate both depolarisa-
tion abnormalities, in the form of delayed conduction latencies
29
and slowed activation patterns,
39 and repolarisation abnormal-
ities in the form of APD heterogeneities and steep restitution
Figure 4 Mechanisms of
arrhythmogenesis in long QT syndrome
from animal models. The scales
demonstrate that associated genetic
mutations result in a gain of
depolarising currents or a loss of
repolarising currents. This in turn
results in triggered activity in the form
of early after-depolarisations, the
formation of refractory pockets and the
generation of abnormal transmural
gradients. The lowest trace shows an
ECG with the initiation of torsade de
pointes recapitulating the clinical
phenotype. All traces shown are from
mice. Adapted in part from Thomas
et al,
42 Stokoe et al
28 and Fabritz
et al,
43 with permission.
Increased depolarisation
currents
Depolarisation
Repolarisation
Long QT syndrome
Decreased repolarisation
currents
Transmural gradients Early afterdepolarisations
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Reviewcurves
13 with an associated propensity to discordant alternans,
20
which may act together to initiate arrhythmias (ﬁgure 3).
Fibrosis and reduced connexin expression associated with
ageing
41 have also been demonstrated, which may contribute to
the slowed conduction and furthermore may itself promote and
maintain differences in repolarisation timing between the
myocardial layers creating optimal conditions for re-entry. Thus,
both structural changes and differences in ion channel kinetics
together create optimal proarrhythmic conditions, and the
disease can be regarded as a combination of a structural
cardiomyopathy in conjunction with a functional channel
anomaly.
Long QT syndrome
LQTS forms a genetically heterogeneous group of conditions,
characterised by prolonged ventricular repolarisation and
increased risk of ventricular arrhythmias, particularly torsade de
pointes. In contrast to BrS, the mutations in LQTS result in
a favouring of depolarising currents over repolarising ones.
Evidence from several mouse models (for references see
27) have
implicated prolonged APD in two major problems generating an
arrhythmic substrate (ﬁgure 4). First, increased refractory
periods from channels that remain depolarised for greater
periods create pockets of functional block, which may act as the
focus for re-entry. Second, differences in dispersion of repolar-
isation across the myocardium may result in a functional
re-entry acting as a trigger for torsade de pointes. EADs are also
more common due to the extended time of depolarisation,
which may in turn trigger polymorphic VT.
Catecholaminergic polymorphic ventricular tachycardia
CPVT presents as syncope or SCD due to the action of increased
catecholamines during exercise or stress resulting in a bidirec-
tional VT. The underlying mechanism of CPVTrevolves around
abnormal Ca
2+ release from the SR, which is often due either to
gain-of-function mutations in the gene encoding RyR2, a critical
Figure 5 Mechanisms of
arrhythmogenesis in catecholaminergic
polymorphic ventricular tachycardia
from animal models. The genetic
mutations result in an increase in
cytosolic Ca
2+ which in turn causes the
scales to tip in favour of depolarising
currents due to the electrogenic nature
of the Na
+/Ca
2+ exchanger. If
sufﬁcient, this may lead to triggered
activity in the form of delayed after-
depolarisations. The lowest trace
shows an ECG with the initiation of
a bidirectional ventricular tachycardia
recapitulating the clinical phenotype. All
traces shown are from mice. Adapted
in part from Cerrone et al
47 and Cerrone
et al,
48 with permission.
Increased depolarising
currents
Depolarisation
Repolarisation
Delayed afterdepolarisations
Catecholaminergic
polymorphic
ventricular tachycardia
Bidirectional ventricular tachycardia
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Reviewregulator of Ca
2+ release from the SR for excitationecontraction
coupling,
44 or loss of function mutations in calsequestrin, a SR
calcium buffering protein.
45
Such abnormal Ca
2+ release may cause DADs, similar to
digitalis toxicity where baseline Ca
2+ is also elevated, resulting
in an arrhythmic trigger
46 (ﬁgure 5). Data from in vitro studies
show that CPVT-associated RyR2 and CASQ2 mutations
84 9
cause cytosolic Ca
2+ overload which generates a net inward
current. Several transgenic mouse models of CPVT have been
developed, harbouring mutations in either RyR2
30 or in
CASQ2,
50 which demonstrate abnormal Ca
2+ transients and
bidirectional VT. These studies have provided evidence that the
transient inward current may underlie the DADs that trigger
abnormal beats in this condition.
Other syndromes
While the majority of cases of SCD in the absence of structural
heart abnormalities are caused by the three syndromes
mentioned above, there are a number of other related syndromes
that have come to light. Short QT syndrome, phenotypically
characterised by short APDs and hence QT intervals, can be
caused by gain-of-function mutations in K
+ channels
51 or loss of
function mutations in Ca
2+ channels.
52 Studies in a canine
pharmacological wedge preparation have implicated increased
transmural repolarisation gradients in the arrhythmogenic
mechanism.
53
Early repolarisation (ER) disease is characterised by ventricular
arrhythmias and sudden death in the presence of an ER pattern
on the ECG as characterised by J-point elevation and prominent
T waves.
54 While preliminary evidence from canine studies
suggests that increased transmural differences in early phases of
the AP may be responsible,
55 the exact mechanism for ER is still
unknown. In rare cases, mutations in genes causing either
a decrease in inward Ca
2+ currents
56 or an increase in outward
K
+ currents
57 have been identiﬁed; however, mutations have not
been identiﬁed in the majority of cases. Given the high
frequency of the genetic background underlying the ER pattern
in the population, the disease is probably polygenic and inﬂu-
enced by environmental factors.
Progressive cardiac conduction disease (PCCD) encompasses
another group of conditions that, while most commonly
manifesting as bradycardia, may also cause SCD. The ﬁrst gene
to be associated with PCCD was SCN5A, and indeed some
SCN5A mutations may be associated with more complex
phenotypes combining characteristics of BrS, PCCD and LQT3,
the so-called ‘overlap syndromes’.
58 More recently, PCCD has
been associated with altered expression of genes encoding other
proteins involved in impulse propagation, including those
responsible for calcium-activated ion channels and cytoskeletal
components. Mouse studies have indicated that the resulting
phenotype appears to develop from a combination of these
genetic factors, environmental modiﬁers and other physiologic
determinants, including ageing.
41
CONCLUSION
A clearer understanding of the underlying causes of inherited
arrhythmias has arisen as a result of basic research, particularly
from engineered mice modelling genetic abnormalities. In
particular, as demonstrated in all of the inherited disorders,
imbalances of current in favour of either depolarisation, such as
in the LQTS and CPVT, or repolarisation, such as in BrS and
short QT syndrome, in a spatially or temporally heterogeneous
fashion may result in foci for re-entrant circuits, potentially
giving rise to major arrhythmia. Linking inherited arrhythmo-
genic syndromes to their genetic and molecular basis offers the
practitioner tools for accurately diagnosing rare disorders and
provides novel markers for assessing risk of SCD. Recognising
the fundamental defects in channelopathies may also provide
the basis for new strategies of treatment, including tailored
pharmacotherapy and gene therapy.
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